Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026827 (
hypotonia
)
5,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HEY2
is a basic helix-loop-helix (bHLH) transcription factor that plays an important role in the developing mammalian heart and brain. In humans, nonsynonymous mutations in
HEY2
have been described in patients with atrial ventricular septal defects, and a subset of individuals with chromosomal deletions involving
HEY2
have cardiac defects and cognitive impairment. Less is known about the potential effects of
HEY2
overexpression. Here, we describe a female child with tetralogy of Fallot who developed severe right ventricular outflow tract obstruction due to a combination of infundibular and valvular pulmonary stenosis. She was also noted to have
hypotonia
, lower extremity weakness, fine motor delay and speech delay. A copy number variation (CNV) detection analysis followed by real-time quantitative PCR analysis revealed a single gene duplication of
HEY2
. This is the only duplication involving
HEY2
identified in our database of over 70,000 individuals referred for CNV analysis. In the developing heart, overexpression of
HEY2
is predicted to cause decreased expression of the cardiac transcription factor GATA4 which, in turn, has been shown to cause tetralogy of Fallot. In mice, misexpression of Hey2 in the developing brain leads to inhibition of neurogenesis and promotion of gliogenesis. Hence, duplication of
HEY2
may be a contributing factor to both the congenital heart defects and the neurodevelopmental problems evident in our patient. These results suggest that individuals with
HEY2
duplications should be screened for congenital heart defects and monitored closely for evidence of developmental delay and/or cognitive impairment.
...
PMID:Duplication of HEY2 in cardiac and neurologic development. 2583 14